Similar articles

• DNA vaccines against human immunodeficiency virus type 1.

  Estcourt MJ, McMichael AJ, Hanke T. Estcourt MJ, et al. Immunol Rev. 2004 Jun;199:144-55. doi: 10.1111/j.0105-2896.2004.00151.x. Immunol Rev. 2004. PMID: 15233732 Review.
• Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.

  De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ. De Rose R, et al. Vaccine. 2005 Mar 14;23(16):1949-56. doi: 10.1016/j.vaccine.2004.10.012. Vaccine. 2005. PMID: 15734067
• HIV/AIDS vaccines: 2007.

  Robinson HL. Robinson HL. Clin Pharmacol Ther. 2007 Dec;82(6):686-93. doi: 10.1038/sj.clpt.6100408. Epub 2007 Oct 31. Clin Pharmacol Ther. 2007. PMID: 17971817 Review.
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

  Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA. Shiver JW, et al. Nature. 2002 Jan 17;415(6869):331-5. doi: 10.1038/415331a. Nature. 2002. PMID: 11797011
• AIDS vaccine development.

  Lévy JP. Lévy JP. Science. 1998 May 8;280(5365):806-7. Science. 1998. PMID: 9599149 No abstract available.